CDRI-97/78   Click here for help

GtoPdb Ligand ID: 10399

Antimalarial Ligand
Compound class: Synthetic organic
Comment: CDRI-97/78 is a novel trioxane peroxide with promising antimalarial activity [2]. It is a simplified analogue of artemisinin and retains the crucial endoperoxide bridge.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 100.52
Molecular weight 500.24
XLogP 5.11
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(OCC(Oc1ccc(cc1)C(=C)C1COC2(OO1)C1CC3CC2CC(C1)C3)(C)C)CCC(=O)O
Isomeric SMILES O=C(OCC(Oc1ccc(cc1)C(=C)C1COC2(OO1)C1CC3CC2CC(C1)C3)(C)C)CCC(=O)O
InChI InChI=1S/C28H36O8/c1-17(24-15-33-28(36-35-24)21-11-18-10-19(13-21)14-22(28)12-18)20-4-6-23(7-5-20)34-27(2,3)16-32-26(31)9-8-25(29)30/h4-7,18-19,21-22,24H,1,8-16H2,2-3H3,(H,29,30)
InChI Key LKAAAECAYCDCQW-UHFFFAOYSA-N
References
1. Shafiq N, Rajagopalan S, Kushwaha HN, Mittal N, Chandurkar N, Bhalla A, Kaur S, Pandhi P, Puri GD, Achuthan S et al.. (2014)
Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug.
Malar Res Treat, 2014: 372521. [PMID:24800100]
2. Singh C, Puri SK. (2001)
Substituted 1,2,4-trioxanes as antimalarial agents and a process of producing the substituted 1,2,4-trioxanes.
Patent number: US6316493B1. Assignee: Council of Scientific and Industrial Research. Priority date: 28/12/1999. Publication date: 13/11/2001.